Mavacamten → Heart failure — Null result

← All findings ⬇ Download signed audit packet

Ledger entry · null-result

Mavacamten → Heart failure — Null result

Drug: mavacamten · AE: Heart failure

Caliper validation of the submitted claim (drug=mavacamten, AE=Heart failure). BELOW_DEDUP_THRESHOLD — candidate did not validate at dedup

Disproportionality

PRR: 3.398721806875557 (95% CI 0.21–54.39)
Yates χ²: 0.8485128656484565
Cases (case-drug + AE): n = 0
Verdict: BELOW_DEDUP_THRESHOLD — candidate did not validate at dedup

Top reactions in cohort

MedDRA PT	n
No reactions surfaced in cohort.

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.

Independent Verification & Validation

Every finding includes an in-engine adversary review at no cost. For findings you plan to cite in a regulatory submission, scientific publication, or board-grade decision, we offer an additional layer of independent, audit-grade verification — reviewed by an externally-trained system that has never seen your data, your training corpus, or our hardware, and cryptographically signed.

Reference: be60dc12e23d5a07a661b7243ffc6010b7811903